A new major player in T cell suppression and tumor control
An inhibitory receptor binds a checkpoint protein to thwart T cell proliferation and function.
cancer immunotherapy
Customizing mRNA vaccines for cancer
Researchers use mRNA to create cancer vaccines that are personalized to each individual’s unique tumor.
Cracking the cancer-neuroscience connection
Cancer anywhere in the body can change brain activity, and brain activity can drive cancer growth. These surprising discoveries are leading to new treatments.
A new era of vaccine development
Pioneering approaches transform vaccine technologies and shape the future of disease prevention.
Powering up natural killer cells to fight cancer
Natural killer cells offer safe and effective cancer treatment, but to succeed in the clinic, they need a bit of an energy boost.
The dual role of microbiota in cancer immunotherapy
Understanding the complex three-way communication between immune cells, the gut microbiome, and cancer sheds light on why immunotherapies fail in some patients but succeed in others.
Advancing immune forces at the tumor frontlines
Epigenetic therapies revive the immune cell offensive in immunotherapy resistant tumors.
The Impact of the Gut Microbiome on Cancer Immunotherapy Efficacy
The complex interplay between bacteria and the tumor microenvironment informs cancer immunotherapy strategies.
Infographic: Immuno-oncology Drug Development Growth
Discover leading immunotherapy targets in the the drug development pipeline.
Tools against tumors
Grant from Innovate UK to Pathios seeks to advance cancer immunotherapy
